Published June 2002 | Version v1
Miscellaneous

Medulloblastoma-change of prognosis in children at one center over the last 30 years

Description

Tumours of the central nervous system are the most common solid tumours in children. Medulloblastoma constitute about 20 % of all brain tumours in children. The peak of incidence is noted between the 4th and 8th year of life. There is a male/female predominancy of approximately 2 to 1. Medulloblastoma is a high-malignant tumour and originates in the posterior fossa. 87 patients were treated for a medulloblastoma at the Department of Neurosurgery at the General Hospital Vienna from January 1969 to December 2000. In this study the change of prognosis in children over the last 30 years should be explored. The 5-year event-free survival rate was between 1969 and 1979 33 %, between 1980 and 1990 64 % and between 1991 and 2000 59 %. Reasons for the improved survival rates from 1980 are the optimal surgical planning with CT and MRT, the MRT of the spinal cord before and after surgery for the purpose of tumor staging (metastases)and the advent of the surgical microscope in 1988. For all that the prognosis of medulloblastoma is poor now as before, because the mean 10-year survival rate is 60 %. Therefore it is necessary to improve the therapy to increase the long-term survival rates. This can be reached only with additional chemotherapy, which has been demonstrated in several studies of famous study groups. (author)

Availability note (English)

Available from Univ. Wien Bibliothek, Dr. Karl Lueger-Ring 1, 1010 Wien (AT)

Additional details

Additional titles

Original title (German)
Medulloblastome - Veraenderung der Prognose bei Kindern ueber einen Zeitraum von 30 Jahren an einem Zentrum

Publishing Information

Imprint Pagination
74 p.

INIS

Country of Publication
Austria
Country of Input or Organization
Austria
INIS RN
35072517
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Thesis, Non-conventional Literature
Descriptors DEI
BRAIN; CHEMOTHERAPY; CHILDREN; METASTASES; NEOPLASMS; RADIOTHERAPY; SURVIVAL TIME
Descriptors DEC
AGE GROUPS; ANIMALS; BODY; CENTRAL NERVOUS SYSTEM; DISEASES; MAMMALS; MAN; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; ORGANS; PRIMATES; RADIOLOGY; THERAPY; VERTEBRATES

Optional Information

Notes
Reference number: